MDA-MB-453 Cells
USUSD$375.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The MDA-MB-453 cell line is a widely studied human breast carcinoma cell line derived from the metastatic site of pleural effusion in a female adult patient. This cell line is known for its utility in breast cancer research due to its unique characteristics, including its androgen receptor (AR) positivity and lack of estrogen receptor (ER) and progesterone receptor (PR) expression. These features make MDA-MB-453 an invaluable model for studying triple-negative breast cancer (TNBC) and the role of androgen receptors in breast cancer progression and therapy resistance. MDA-MB-453 cells exhibit epithelial morphology and adhere to culture surfaces, forming polygonal cell shapes. The cell line is also characterized by its high proliferative capacity and ability to grow in vitro and in vivo, which is essential for preclinical studies involving drug testing and the investigation of molecular pathways. Genetic analysis of MDA-MB-453 cells reveals mutations in key oncogenes and tumor suppressors, including the PIK3CA gene, which is often implicated in cancer cell survival and growth. These cells are also utilized in the study of targeted therapies, particularly those aimed at the PI3K/AKT/mTOR signaling pathway and AR inhibitors, to develop more effective treatments for TNBC patients. |
|---|---|
| 生物體 | Human |
| 組織 | Mammary gland, breast |
| 疾病 | Adenocarcinoma |
| 轉移部位 | Pericardial effusion |
| 同義詞 | MDA-MB 453, MDA MB 453, MDA-MB453, MDAMB453, MDA-453, MDA453, MD Anderson-Metastatic Breast-453 |
特徵
| 年齡 | 48 years |
|---|---|
| 性別 | Female |
| 族裔 | European |
| 形態學 | Epithelial |
| 生長特性 | Adherent |
監管數據
| 引用 | MDA-MB-453 (Cytion catalog number 305042) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_0418 |
生物分子資料
| 受體的表達 | Fibroblast growth factor(FGF), expressed |
|---|---|
| 致瘤性 | No |
處理方式
| 培養基 | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305042-261125 | 分析證明書 | 15. Jan. 2026 | 305042 |
-
Related products
Related products
MDA-MB-175-VII Cells生物體 Human 組織 Metastatic 疾病 Invasive breast carcinoma of no special type USUSD$550.00*